AbbVie Balance Sheet Health
Financial Health criteria checks 2/6
AbbVie has a total shareholder equity of $-138.0M and total debt of $70.6B, which brings its debt-to-equity ratio to -51148.6%. Its total assets and total liabilities are $137.2B and $137.3B respectively. AbbVie's EBIT is $19.8B making its interest coverage ratio 7.9. It has cash and short-term investments of $6.5B.
Key information
-51,148.55%
Debt to equity ratio
US$70.59b
Debt
| Interest coverage ratio | 7.9x |
| Cash | US$6.47b |
| Equity | -US$138.00m |
| Total liabilities | US$137.32b |
| Total assets | US$137.18b |
Recent financial health updates
No updates
Recent updates
AbbVie: Wins Accumulating While We Wait For Next BD Steps
Oct 03AbbVie's (NYSE:ABBV) Soft Earnings Are Actually Better Than They Appear
May 16
AbbVie Q1 Earnings Review: Typically Strong Performance, Aesthetics Aside
Apr 25AbbVie: Thriving Beyond Humira's Patent Cliff (Upgrade)
Apr 09AbbVie Vs. Sanofi: Which Is The Better Investment Right Now
Mar 28AbbVie Is Preparing To Challenge Eli Lilly And Novo Nordisk
Mar 13Investors Don't See Light At End Of AbbVie Inc.'s (NYSE:ABBV) Tunnel
Feb 25Why AbbVie Remains A Strong Buy For Long-Term Investors
Feb 23AbbVie: An Undervalued Dividend Aristocrat
Feb 14AbbVie: Q4 2024 Earnings Preview And Update On Emraclidine
Jan 26AbbVie's Stock Is Unfairly Cheap
Jan 09AbbVie's (NYSE:ABBV) Shareholders Will Receive A Bigger Dividend Than Last Year
Jan 03Betting Big On AbbVie: A Prescription For Growth And Dividends
Dec 11AbbVie (NYSE:ABBV) Will Pay A Larger Dividend Than Last Year At $1.64
Dec 09AbbVie: Upgrading To 'Strong Buy' After Pullback
Nov 22AbbVie's (NYSE:ABBV) Dividend Will Be Increased To $1.64
Nov 19AbbVie's (NYSE:ABBV) Soft Earnings Are Actually Better Than They Appear
Nov 12Financial Position Analysis
Short Term Liabilities: ABBV has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: ABBV has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: ABBV has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: ABBV's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Debt Coverage: ABBV's debt is well covered by operating cash flow (27.3%).
Interest Coverage: ABBV's interest payments on its debt are well covered by EBIT (7.9x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/14 04:00 |
| End of Day Share Price | 2025/10/14 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
AbbVie Inc. is covered by 50 analysts. 26 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Toung | Argus Research Company |
| Luisa Hector | Berenberg |
| Evan Seigerman | BMO Capital Markets Equity Research |